000 01369 a2200385 4500
005 20250516181327.0
264 0 _c20140313
008 201403s 0 0 eng d
022 _a1468-2044
024 7 _a10.1136/archdischild-2013-304473
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHird, Beverly E
245 0 0 _aNo evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.
_h[electronic resource]
260 _bArchives of disease in childhood
_cFeb 2014
300 _a158-64 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _a17-alpha-Hydroxyprogesterone
_xblood
650 0 4 _aAdrenal Hyperplasia, Congenital
_xblood
650 0 4 _aDNA Mutational Analysis
650 0 4 _aEngland
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aInfant, Newborn
650 0 4 _aMale
650 0 4 _aNeonatal Screening
_xstatistics & numerical data
650 0 4 _aPoint Mutation
650 0 4 _aRetrospective Studies
700 1 _aTetlow, Lesley
700 1 _aTobi, Simon
700 1 _aPatel, Leena
700 1 _aClayton, Peter E
773 0 _tArchives of disease in childhood
_gvol. 99
_gno. 2
_gp. 158-64
856 4 0 _uhttps://doi.org/10.1136/archdischild-2013-304473
_zAvailable from publisher's website
999 _c23261007
_d23261007